The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
| ||||||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| 2seventy bio, Inc. | Common Stock | 901384107 | 3,689,191 | 1,254,827 | SH | SOLE | 1,254,827 | 0 | 0 | ||
| Adicet Bio, Inc. | Common Stock | 007002108 | 931,392 | 968,183 | SH | SOLE | 968,183 | 0 | 0 | ||
| Adverum Biotechnologies, Inc. | Common Stock | 00773U207 | 844,845 | 180,909 | SH | SOLE | 180,909 | 0 | 0 | ||
| Alnylam Pharmaceuticals, Inc. | Common Stock | 02043Q107 | 1,045,822,353 | 4,444,445 | SH | SOLE | 4,444,445 | 0 | 0 | ||
| bluebird bio, Inc. | Common Stock | 09609G209 | 175,140 | 21,000 | SH | SOLE | 21,000 | 0 | 0 | ||
| Intellia Therapeutics, Inc. | Common Stock | 45826J105 | 43,176,922 | 3,702,995 | SH | SOLE | 3,702,995 | 0 | 0 | ||
